Tag: research

Gilead Sciences
United States

Gilead Sciences Announces Completion of Acquisition of CymaBay

Acquisition Reinforces Gilead’s Leadership in Developing Innovative Therapies For Challenging Liver Diseases March 22, 2024 09:18 AM Eastern Daylight Time FOSTER CITY, Calif.–(BUSINESS WIRE)–Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in total equity value. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of … Continue reading Gilead Sciences Announces Completion of Acquisition of CymaBay

Impact Newswire
A2 Bio
United States

A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Robinson to Lead Next Phase of Company’s Expansion and Pipeline Advancement March 25, 2024 09:00 AM Eastern Daylight Time AGOURA HILLS, Calif.–(BUSINESS WIRE)–A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies to address the high unmet needs in cancer, today announced the appointment of James Robinson as its Chief Executive Officer and a member of its Board of Directors, … Continue reading A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors

Impact Newswire
CargoMetrics
United States

CargoMetrics Launches Global Maritime Emissions Data Products

Maritime data analytics vanguard releases first of their kind emissions and fuel consumption products for benchmarking, monitoring, and carbon trading – conveniently available on AWS Data Exchange March 21, 2024 09:26 AM Eastern Daylight Time BOSTON–(BUSINESS WIRE)–CargoMetrics, a global leader in the systematic monitoring and analysis of maritime trade, has announced the launch of new products that measure maritime emissions and provide trusted, unbiased data … Continue reading CargoMetrics Launches Global Maritime Emissions Data Products

Impact Newswire
Apollo Intelligence
United States

Apollo Intelligence Wins 2024 Artificial Intelligence Excellence Award

With NLP and ML features in the Apollo Intelligence Next-Generation Platform for Market Insights, life science firms can gain significantly greater speed to insights and higher quality data March 20, 2024 09:00 AM Eastern Daylight Time WATERTOWN, Mass.–(BUSINESS WIRE)–Apollo Intelligence (Apollo), a leading provider of real-time data and insights to the healthcare and life science industries, was named a winner in the 2024 Artificial Intelligence Excellence Awards … Continue reading Apollo Intelligence Wins 2024 Artificial Intelligence Excellence Award

Impact Newswire
Enhanc3D Genomics
Global, United States

Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships CAMBRIDGE, England–(BUSINESS WIRE)–Enhanc3D Genomics, a company developing disruptive technologies to unlock the 3D spatial genome for target and biomarker discovery, today announced the appointment of Dr Daniel Turner as Chief Scientific Officer (CSO). Dan’s deep expertise in genomics technology development and commercialisation will be … Continue reading Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer

Impact Newswire
Depixus
Europe, Global

Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

PARIS–(BUSINESS WIRE)–Interactomics pioneer Depixus has appointed experienced life sciences sales leader, Steve Klose, to the newly created role of Chief Commercial Officer from January 16, 2024. Klose will lead the company’s commercial growth strategy to build a highly effective sales and support organization, strengthening its market presence ahead of the commercial launch of its first laboratory instrument, MAGNA One™, in 2024. “I’m thrilled to have … Continue reading Depixus Appoints Steve Klose as Chief Commercial Officer to Drive the Commercialization of Its Groundbreaking MAGNA™ Technology

Impact Newswire
Aiolos Bio
Global, United States

GSK Enters Agreement to Acquire Aiolos Bio

January 09, 2024 05:52 AM Eastern Standard Time SAN FRANCISCO & LONDON–(BUSINESS WIRE)–GSK plc (LSE/NYSE: GSK) and Aiolos Bio, Inc. (Aiolos) today announced that they have entered into an agreement under which GSK will acquire Aiolos, a clinical-stage biopharmaceutical company focused on addressing the unmet treatment needs of patients with certain respiratory and inflammatory conditions, for a $1 billion upfront payment and up to $400 … Continue reading GSK Enters Agreement to Acquire Aiolos Bio

Impact Newswire
Immunome, Inc.
Global, United States

Immunome Appoints Phil Roberts as Chief Technical Officer

January 04, 2024 08:00 AM Eastern Standard Time BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the appointment of Phil Roberts as Chief Technical Officer. Mr. Roberts has over three decades of experience in product development, global manufacturing, and commercialization of novel pharmaceutical products. “Working with Clay and the entire Immunome team to … Continue reading Immunome Appoints Phil Roberts as Chief Technical Officer

Impact Newswire